Similarly, melanoma-specific antigens (TRP-1, TRP-2, gp100, and MART-1 derived peptides) with Cys at their C-terminus were conjugated to antibodies using the sulfhydryl-maleimide reaction [96]. The gene discussed is MLANA; the disease is melanoma.